Leading Companies

NOUSCOM AG

Nouscom is a biotech company developing next generation immunotherapies in the field of oncology. Nouscom’s proprietary technology platform, Exovax, harnesses the full power of immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators.

NOUSCOM AG

Bäumleingasse 18
4051 Basel
Switzerland


Settori
Bio Technology (Biotech)
Life Science
Country of Origin
Italia
Condividere

Premium Partner

Partner strategici

Partner istituzionale

Programma ufficiale